
How to Protect Yourself From Saharan Dust
Such events occur in the Caribbean and the Gulf Coast region several times a year, and scientists are studying how climate change may affect their frequency and intensity.
Here is what research shows about the health effects of Saharan dust exposure, and how people can protect themselves.
What is in the dust plume?
Dust plumes like this one originate in deserts, in this case, the Sahara. The dust is composed mainly of minerals found in desert sand, including silicates such as quartz.
But as they travel, plumes can pick up other pollutants, as well as bacteria, viruses and fungi. Reactions among the pollutants, and between those pollutants and sunlight, can produce additional chemicals as well.
What are the effects of exposure?
What makes Saharan dust dangerous is that its particles are extremely small, which means they can be inhaled deep into the lungs, irritating and damaging them.
Want all of The Times? Subscribe.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Life might have come from outer space, scientist say
The seeds of life on Earth might have come from outer space – and might be widespread throughout the rest of the universe, scientist say. Researchers have found complex organic molecules in a disc around a 'protostar' in a major breakthrough. Those molecules are seen as the precursors to the building blocks of life, which go on to become sugars and amino acids that are then combined into the complex flora and fauna that surrounds us. Researchers have found such complex organic molecules in other places before. But the new findings fill in a previously mysterious missing link – one that could suggest that life is more abundant than we realise. When cold protostar becomes a young star, surrounded by a disc of dust and gas, it is a violent process that includes intense radiation and the hurling out of gas. Researchers had been concerned that the extreme nature of that process could 'reset' the chemical compounds available around a star, meaning that they would have to be formed in the discs that at the same time are making planets. But the new findings suggest that complex molecules can stick around through that process, meaning they will be inherited by the discs that follow. The findings are reported in a new study, 'A deep search for Complex Organic Molecules toward the protoplanetary disk of V883 Ori', published in the The Astrophysical Journal Letters.
Yahoo
4 hours ago
- Yahoo
Knee Replacement Surgery Market worth $16.17 billion in 2030 with 6.1% CAGR
DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The global Knee Replacement Surgery Market, valued at US$10.86 billion in 2023 stood at US$12.00 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$16.17 billion by the end of the period. The key factor propelling the market is the increasing prevalence of osteoarthritis, particularly among the aging population. This increase in cases is driving a higher demand for surgical interventions, including total and partial knee replacements. As life expectancy increases and age-associated degenerative changes to the knee joint become more pronounced, the necessity for these procedures is escalating. This demographic shift is a significant catalyst for market expansion, contributing to a growing global patient population requiring knee treatment solutions. Download PDF Brochure: Browse in-depth TOC on "Knee Replacement Surgery Market" 300 - Tables55 - Figures400 - Pages By product, the global knee replacement surgery market is segmented into knee implants, knee braces & support systems, and orthobiologics. The orthobiologics segment is expected to register significant growth over the forecast period. A growing number of patients are opting for non-surgical interventions to manage their conditions. Orthobiologics, such as Platelet-Rich Plasma (PRP) therapy, stem cell treatments, and hyaluronic acid injections, provide less invasive alternatives that enhance healing and stimulate tissue regeneration. These modalities are particularly beneficial for patients with early to moderate osteoarthritis, where conventional surgical interventions may be premature or unnecessary. By application, the global knee replacement surgery market is segmented into osteoarthritis & rheumatoid arthritis, degenerative disease, cancer, and other applications. The Centers for Disease Control and Prevention (CDC) reports that approximately 319,000 individuals aged 65 and older are hospitalized annually in the United States due to hip fractures. Surgical intervention typically involves the use of fixation devices that stabilize the fractured bone by immobilizing it, thereby providing a protective framework that facilitates healing. The incorporation of orthobiologics into orthopedic procedures is gaining traction, as these biological agents enhance the regenerative capacity of tissues and promote faster recovery. With the increasing prevalence of conditions such as rheumatoid arthritis and osteoarthritis, coupled with a growing geriatric population, there is a projected surge in the adoption of knee surgery devices to address these joint pathologies effectively. By end user, the end user segment of the knee replacement surgery market includes hospitals, ambulatory surgery centers, and orthopedic clinics. In 2024, hospitals accounted for the largest market share. Recent advancements in surgical technologies, anesthesia techniques, and shifts in Medicare reimbursement policies have driven an escalation in orthopedic procedures within outpatient environments, particularly ambulatory surgery centers. These developments are poised to significantly enhance the expansion of the ASC market. Consequently, we can anticipate a marked increase in the volume of knee arthroplasties conducted in these settings, thereby further propelling the growth of the ASC segment in the near future. Request Sample Pages : As of 2024, prominent players in the knee replacement surgery market are Zimmer Biomet (US), Stryker (US), Johnson & Johnson, Inc. (US), Smith+Nephew PLC (UK), and B. Braun (Germany). Stryker (US): Stryker ranks among the top firms in the global knee replacement surgery market. The organization has established a formidable presence in the global market, extending its operational reach across key regions, including Europe, North America, the Middle East, Africa, and the Asia Pacific. With a successful track record in more than 75 countries, the company has effectively built a strong brand recognition, particularly through its Orthopedics division, which specializes in advanced surgical devices for knee treatments. Driven by a commitment to growth, the firm continuously seeks to broaden its product portfolio, ensuring that it remains at the forefront of innovation by launching groundbreaking solutions tailored to meet the evolving demands of the market. To maintain its competitive advantage, the organization places a high priority on innovation and the creation of unique, differentiated products that stand out in an increasingly crowded marketplace. A central element of its strategy is a substantial investment in R&D, which fuels the introduction of pioneering technologies. These advancements are specifically designed to address the pressing, unmet needs of healthcare providers and patients, thereby enhancing treatment outcomes and improving the quality of care within the healthcare system. Zimmer Biomet (US) Zimmer Biomet (US) is among the leading companies in the global knee replacement surgery market. The firm is a key player in the healthcare industry, specializing in the production and distribution of a diverse range of medical devices and healthcare products designed to meet various medical needs. With a robust presence across multiple international markets, the company operates in notable countries such as Germany, where it taps into a highly developed healthcare system; France, which is known for its emphasis on innovation in medicine; and Italy, which has a rich history of medical advancements. In addition to these European nations, the firm's influence extends to Switzerland, renowned for its high-quality healthcare, as well as Spain and the UK, both of which represent significant markets for medical technology. The firm also maintains a strong foothold in Asia, including major economies such as Japan and South Korea, which are recognized for their cutting-edge healthcare technologies. Further expanding its global reach, the firm has established a presence in China, one of the fastest-growing healthcare markets in the world, as well as in Australia and New Zealand, where it provides vital healthcare solutions. The company is also active in Taiwan, India, Hong Kong, Thailand, Singapore, and Malaysia, where it meets the diverse medical needs of these dynamic populations. To support its extensive operations, the firm has developed a comprehensive distribution network that spans Benelux (Belgium, Netherlands, and Luxembourg) and the Nordic countries, ensuring effective market penetration in Central and Eastern Europe. Additionally, the firm has made significant inroads in the Middle East and Africa, regions that are increasingly recognizing the importance of advanced medical technology in improving healthcare outcomes. This strategic global presence not only enhances the firm's competitiveness but also reinforces its commitment to advancing healthcare worldwide. Johnson & Johnson Services, Inc. (US) Johnson & Johnson Services, Inc. (US) is a prominent entity within the knee replacement surgery sector, engaged in the comprehensive manufacturing, R&D, and global marketing of joint replacement technologies and related healthcare products. Operating under the MedTech business segment, it specializes in advancing knee replacement surgery products aimed at improving clinical outcomes through innovative technology. In a strategic collaboration with CrossRoads Extremity Systems (US), the company is focused on enhancing orthopedic care by integrating novel ideas to provide patients with superior health benefits. The firm commands a substantial market share across more than 60 countries, spanning multiple regions, including Asia Pacific, North America, the Middle East & Africa, and Europe. Additionally, it operates through a robust portfolio of key subsidiaries, which includes DePuy, Inc. (US), Animas Corporation (US), Ethicon, Inc. (US), and LifeScan, Inc. (US). For more information, Inquire Now! Related Reports: Joint Replacement Devices Market Orthopedic Braces & Supports Market Medical Robots Market Surgical Robots Market Minimally Invasive Surgical Instruments Market Get access to the latest updates on Knee Replacement Surgery Companies and Knee Replacement Surgery Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets

Associated Press
4 hours ago
- Associated Press
Leaping sturgeon provide a show for nature lovers on Maine rivers
AUGUSTA, Maine (AP) — The Kennebec River in Maine's capital city of Augusta is known for its population of Atlantic and shortnose sturgeon. The fish sometimes leap completely from the water, as at least one did on Wednesday. The shortnose population on the river nearly doubled from about 5,100 in the late 1970s to more than 9,400 around 2000, and it has likely grown since, state biologists have said. The ancient fish have also shown signs of recovering elsewhere in Maine, such as the Saco River further south. Scientists have proposed a number of reasons why sturgeon jump out of the water, including regulating their swim bladder, communicating with other sturgeon, shedding parasites and avoiding predators. Shortnose sturgeon can weigh up to 60 pounds (27 kilograms), while Atlantic sturgeon can be much larger, with some weighing as much as 800 pounds (363 kilograms). The fish thrill nature lovers who are fortunate to catch their sudden leaps along Maine rivers. Catching a glimpse of them is often a matter of luck.